🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate that a fixed-dose combination of telmisartan 40 mg plus amlo...
Status
Completed
Location
1235.13.037 Boehringer Ingelheim Investigational Site
Start Date
2007-10
Trial ID
NCT00558064
Treatments Being Tested
Evaluation of 24-hour antihypertensive effect of long-acting ARB-CCB tablet...
Status
Unknown
Location
Uchiyama Clinic
Start Date
2012-11
Trial ID
NCT01748253
This observational study is designed to evaluate the effects of Twynsta tab...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 15
Start Date
2011-03
Trial ID
NCT01316419
Treatments Being Tested
A non-randomized, two-arm, single-sequence, crossover, open label, multiple...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02933658
Treatments Being Tested
Evaluation of the Efficacy and Safety of S-amlodipine+Chlorthalidone Combin...
Status
Unknown
Location
Hallym University Medical Center
Start Date
2015-12-02
Trial ID
NCT03226340
Treatments Being Tested
To demonstrate the bioequivalence of 80 mg telmisartan / 10 mg amlodipine f...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT02193308
Treatments Being Tested
Study to investigate the steady state pharmacokinetics of 80 mg telmisartan...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT02259816
Treatments Being Tested
To assess drug drug interaction through pharmacokinetics investigation at s...
Status
Completed
Location
1348.5.001 Boehringer Ingelheim Investigational Site
Start Date
2014-07
Trial ID
NCT02183675
Treatments Being Tested
Recent hypertension guidelines recommend combination therapy as initial tre...
Status
Completed
Location
Elite Clinical Studies
Start Date
2021-07-09
Trial ID
NCT04518293
Treatments Being Tested
The primary objective of this trial is to assess the efficacy and safety of...
Status
Completed
Location
1235.7.32004 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00614380